Flame Biosciences

Flame Biosciences is a clinical-stage company dedicated to developing value-added drugs in the emerging field of inflammasome science. The company is committed to the research, development, and commercialization of transformative therapies for cancer and other inflammatory diseases. Its pipeline currently focuses on treating life-threatening cancers, chronic kidney diseases, and other conditions triggered by chronic inflammation.